News › Clinical Practice, Industry News, Patient Care

FDA Approves Juvéderm Voluma XC for Enhancement of the Chin Region

June 15, 2020

Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.1 The Juvéderm collection of fillers has a broad portfolio of specifically tailored treatment options, and this latest approval marks its fifth approved indication in the U.S.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
Advertisement